Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (352)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
2023
280
5.820
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2022
1438
1.570
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
9
2023
62
1.520
Why?
Down Syndrome
5
2019
361
1.510
Why?
Asparaginase
8
2020
30
1.010
Why?
Burkitt Lymphoma
2
2020
54
0.880
Why?
Consolidation Chemotherapy
2
2019
9
0.790
Why?
Child
64
2023
19282
0.790
Why?
Leukemia, Myeloid, Acute
5
2022
529
0.760
Why?
Child, Preschool
44
2023
9776
0.660
Why?
Leukemia
4
2021
212
0.650
Why?
Mercaptopurine
5
2017
16
0.610
Why?
Oncogene Proteins, Fusion
5
2021
205
0.570
Why?
Disease-Free Survival
10
2022
678
0.550
Why?
Antineoplastic Agents
7
2019
2017
0.550
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
93
0.540
Why?
Preleukemia
1
2015
2
0.540
Why?
Neoplasm Recurrence, Local
3
2021
884
0.530
Why?
Drug Hypersensitivity
3
2017
83
0.520
Why?
Molecular Targeted Therapy
3
2021
373
0.510
Why?
Leukemia, Monocytic, Acute
1
2014
4
0.510
Why?
Sarcoma, Myeloid
1
2014
4
0.510
Why?
Prognosis
13
2021
3603
0.480
Why?
Bone Marrow Transplantation
1
2014
261
0.460
Why?
Infant
31
2023
8440
0.450
Why?
Acute Kidney Injury
1
2019
651
0.450
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
18
0.440
Why?
Neoplasm, Residual
6
2021
99
0.440
Why?
Erwinia
2
2020
3
0.430
Why?
Tumor Suppressor Proteins
3
1999
302
0.420
Why?
Chromosome Aberrations
2
2022
136
0.420
Why?
Adolescent
36
2023
19126
0.410
Why?
Neutropenia
2
2022
131
0.410
Why?
Hematopoietic Stem Cell Transplantation
2
2019
542
0.410
Why?
Stem Cell Transplantation
3
2019
153
0.390
Why?
Humans
76
2023
121869
0.390
Why?
Male
53
2023
60475
0.390
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
89
0.390
Why?
Rhabdomyosarcoma
1
2011
61
0.380
Why?
Sarcoma, Ewing
1
2011
71
0.380
Why?
Cell Cycle Proteins
3
1999
576
0.380
Why?
Carrier Proteins
3
1999
740
0.370
Why?
Ploidies
2
2019
19
0.360
Why?
Recurrence
8
2022
1002
0.360
Why?
Catheter-Related Infections
2
2022
67
0.350
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
29
0.340
Why?
Cyclophosphamide
4
2019
225
0.340
Why?
Genes, Tumor Suppressor
2
1999
82
0.340
Why?
Catheterization, Central Venous
2
2022
96
0.330
Why?
Philadelphia Chromosome
2
2018
15
0.320
Why?
Female
50
2023
63903
0.320
Why?
Survival Rate
7
2021
1828
0.300
Why?
Vincristine
4
2021
101
0.290
Why?
Gene Deletion
2
1998
361
0.290
Why?
Medication Adherence
3
2017
573
0.290
Why?
Trisomy
2
2021
67
0.290
Why?
Antimetabolites, Antineoplastic
2
2017
83
0.280
Why?
Etoposide
2
2019
159
0.280
Why?
Neoplasm Proteins
2
2018
414
0.280
Why?
Anxiety
3
2016
873
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
66
0.250
Why?
Treatment Outcome
11
2022
9654
0.230
Why?
Young Adult
13
2023
11223
0.230
Why?
Medical Oncology
4
2022
229
0.230
Why?
Gene Rearrangement
3
2019
157
0.220
Why?
Polyethylene Glycols
5
2020
567
0.220
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
58
0.220
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
2
0.220
Why?
Induction Chemotherapy
2
2019
58
0.220
Why?
Central Venous Catheters
1
2022
40
0.210
Why?
Doxorubicin
2
2022
312
0.210
Why?
Lymphoma
1
2023
185
0.210
Why?
Prednisone
2
2019
239
0.200
Why?
Program Evaluation
2
2017
876
0.200
Why?
Lung Neoplasms
1
2014
2237
0.200
Why?
Adult
21
2023
32683
0.200
Why?
Translocation, Genetic
2
2013
92
0.190
Why?
Maintenance Chemotherapy
2
2017
24
0.190
Why?
Bacterial Infections
1
2022
228
0.190
Why?
Polymorphism, Single Nucleotide
3
2017
2107
0.190
Why?
Risk Factors
11
2022
9419
0.180
Why?
Diploidy
1
2019
14
0.180
Why?
Immunocompromised Host
1
2021
209
0.180
Why?
Genes, p16
1
1999
20
0.180
Why?
Antibodies, Bispecific
1
2019
30
0.180
Why?
Hyperglycemia
1
2023
325
0.180
Why?
Prospective Studies
9
2022
6629
0.170
Why?
PAX5 Transcription Factor
1
2019
27
0.170
Why?
Myelodysplastic Syndromes
1
2020
111
0.170
Why?
Chromosomes, Human, Pair 19
1
1998
27
0.170
Why?
Chromosomes, Human, Pair 17
1
1998
63
0.170
Why?
Rituximab
1
2019
158
0.170
Why?
Mutagenesis
1
1999
182
0.170
Why?
Chromosomes, Human, Pair 1
1
1998
76
0.170
Why?
Patient Safety
1
2021
308
0.160
Why?
Prostate-Specific Antigen
2
2009
173
0.160
Why?
Quality of Life
2
2021
2453
0.160
Why?
Substance Withdrawal Syndrome
1
2020
184
0.160
Why?
Proto-Oncogenes
1
1997
28
0.160
Why?
Oncologists
1
2017
29
0.160
Why?
Thionucleotides
1
2017
34
0.160
Why?
Thioguanine
1
2017
21
0.150
Why?
Apyrase
1
2017
15
0.150
Why?
Family Relations
2
2016
90
0.150
Why?
Blast Crisis
1
2016
19
0.150
Why?
Follow-Up Studies
6
2021
4883
0.150
Why?
Carboxypeptidases A
1
2016
2
0.150
Why?
Retrospective Studies
9
2023
13063
0.150
Why?
Sepsis
1
2022
493
0.140
Why?
Depression
2
2016
1201
0.140
Why?
Pediatricians
1
2017
115
0.140
Why?
Genomics
2
2022
687
0.140
Why?
Mentors
2
2017
164
0.140
Why?
Osteonecrosis
1
2015
21
0.140
Why?
Mentoring
1
2017
105
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
300
0.140
Why?
Nausea
1
2016
109
0.140
Why?
Central Nervous System Neoplasms
1
2017
125
0.140
Why?
Adrenal Cortex Hormones
1
2019
525
0.130
Why?
Pancreatitis
1
2016
110
0.130
Why?
Longitudinal Studies
7
2016
2652
0.130
Why?
Dexamethasone
4
2021
313
0.130
Why?
Mutation
4
2022
3520
0.130
Why?
Fusion Proteins, bcr-abl
2
2016
61
0.130
Why?
Bacteremia
1
2016
164
0.130
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.130
Why?
Monitoring, Physiologic
1
2017
285
0.130
Why?
High-Throughput Nucleotide Sequencing
1
2017
468
0.130
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
66
0.130
Why?
Antigens, CD
1
2017
468
0.130
Why?
Flow Cytometry
1
2018
1108
0.120
Why?
Cross Infection
1
2016
221
0.120
Why?
Repressor Proteins
1
1997
393
0.120
Why?
Histone-Lysine N-Methyltransferase
2
2010
99
0.120
Why?
Immunotherapy
1
2018
493
0.120
Why?
Pediatrics
3
2021
1002
0.120
Why?
Chromosomes, Human, Pair 21
1
2013
32
0.120
Why?
Life Change Events
1
2014
142
0.120
Why?
Venous Thromboembolism
1
2017
235
0.120
Why?
Quality Improvement
1
2021
996
0.120
Why?
DNA-Binding Proteins
2
1998
1392
0.120
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
8
0.110
Why?
Self Report
1
2017
740
0.110
Why?
Karyotyping
3
2019
105
0.110
Why?
Myeloproliferative Disorders
1
2012
26
0.110
Why?
Transcription Factors
2
1998
1629
0.110
Why?
Arabinonucleosides
1
2011
8
0.110
Why?
Adenine Nucleotides
1
2011
20
0.110
Why?
Contraindications
1
2012
100
0.110
Why?
Antibodies, Monoclonal
1
2018
1289
0.100
Why?
Cohort Studies
5
2021
5300
0.100
Why?
Prostatic Neoplasms
2
2009
1024
0.100
Why?
Chromosomes, Human, Pair 4
1
2010
33
0.100
Why?
Chromosomes, Human, Pair 10
1
2010
20
0.100
Why?
Pain
1
2016
745
0.090
Why?
T-Lymphocytes
1
2018
1796
0.090
Why?
Multivariate Analysis
4
2015
1574
0.090
Why?
Parents
2
2016
1255
0.090
Why?
Age Factors
8
2019
3173
0.090
Why?
Prostatectomy
1
2009
111
0.090
Why?
Bloom Syndrome
1
1988
1
0.090
Why?
Neoplasm Metastasis
1
2011
591
0.080
Why?
Juxtaglomerular Apparatus
1
2007
1
0.080
Why?
Gene Expression Regulation, Leukemic
2
2016
49
0.080
Why?
Polymerase Chain Reaction
1
2010
1033
0.080
Why?
Blood Coagulation
1
2008
234
0.070
Why?
Drug Administration Schedule
2
2017
770
0.070
Why?
Stress, Psychological
1
2014
1067
0.070
Why?
Methotrexate
2
2017
236
0.070
Why?
Remission Induction
2
2019
255
0.070
Why?
Drug Monitoring
2
2017
188
0.070
Why?
Acute Disease
2
2019
986
0.060
Why?
Personal Satisfaction
2
2017
190
0.060
Why?
Administration, Oral
2
2017
793
0.060
Why?
Kidney Neoplasms
1
2007
342
0.060
Why?
Genetic Variation
1
1988
961
0.060
Why?
Randomized Controlled Trials as Topic
2
2020
1254
0.060
Why?
Disease Progression
2
2021
2582
0.060
Why?
Proto-Oncogene Proteins c-cbl
1
2022
12
0.050
Why?
Risk
5
2023
925
0.050
Why?
Transcriptome
2
2019
783
0.050
Why?
Incidence
2
2019
2520
0.050
Why?
Drug Therapy
1
2021
73
0.050
Why?
Exome
1
2022
226
0.050
Why?
Diarrhea
2
1999
180
0.050
Why?
Bone Marrow
1
2022
259
0.050
Why?
Risk Assessment
3
2017
3248
0.050
Why?
Surveys and Questionnaires
3
2017
4922
0.050
Why?
Endocrine Glands
1
1979
16
0.050
Why?
Blood Cell Count
1
1999
62
0.050
Why?
Viral Load
1
2021
432
0.050
Why?
Chromosomes, Human
1
2019
43
0.050
Why?
Azacitidine
1
2020
116
0.040
Why?
Loss of Heterozygosity
1
1999
38
0.040
Why?
Cytogenetic Analysis
1
2019
27
0.040
Why?
Mosaicism
1
2019
59
0.040
Why?
Interviews as Topic
1
2021
604
0.040
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
170
0.040
Why?
Genome-Wide Association Study
2
2016
1355
0.040
Why?
Disinfectants
1
1999
35
0.040
Why?
Infant, Newborn
4
2019
5336
0.040
Why?
Sequence Deletion
1
1999
178
0.040
Why?
Chromosomes
1
2019
89
0.040
Why?
National Cancer Institute (U.S.)
1
2018
42
0.040
Why?
United States
4
2021
13209
0.040
Why?
Overweight
1
2023
544
0.040
Why?
Escherichia coli O157
1
1998
32
0.040
Why?
Hypertension
1
2007
1241
0.040
Why?
Methylation
1
1998
215
0.040
Why?
Feasibility Studies
1
2021
779
0.040
Why?
Community Participation
1
1999
126
0.040
Why?
Erythrocyte Count
1
2017
20
0.040
Why?
Family
1
2021
596
0.040
Why?
Public Health Surveillance
1
2017
63
0.040
Why?
Food-Drug Interactions
1
2017
6
0.040
Why?
Leucovorin
1
2017
46
0.040
Why?
Glucose
1
2023
962
0.040
Why?
Escherichia coli Infections
1
1998
113
0.040
Why?
Injections, Intramuscular
1
2017
127
0.040
Why?
Biopsy
1
2021
1090
0.040
Why?
Water Purification
1
1999
115
0.040
Why?
Career Mobility
1
2017
72
0.040
Why?
Proto-Oncogene Proteins c-ets
1
1997
57
0.040
Why?
Genetic Predisposition to Disease
2
2017
2377
0.040
Why?
Dairy Products
1
2017
30
0.040
Why?
Qualitative Research
1
2021
891
0.040
Why?
Cranial Irradiation
1
2017
64
0.040
Why?
Cerebrospinal Fluid
1
2017
92
0.040
Why?
Sulfonamides
1
2020
458
0.040
Why?
MEF2 Transcription Factors
1
2016
59
0.040
Why?
Infusions, Intravenous
1
2017
387
0.040
Why?
Methyltransferases
1
2017
63
0.040
Why?
Leukocyte Count
1
2017
319
0.040
Why?
NIH 3T3 Cells
1
2016
142
0.040
Why?
Luciferases
1
2016
152
0.040
Why?
Middle Aged
10
2019
28961
0.040
Why?
Methyl Ethers
1
1996
8
0.040
Why?
Anesthetics, Inhalation
1
1996
15
0.040
Why?
Ethers
1
1996
18
0.040
Why?
Breast Neoplasms
5
1979
1970
0.040
Why?
Bone Morphogenetic Protein 7
1
2015
10
0.040
Why?
Fluorides
1
1996
50
0.040
Why?
Cytarabine
1
2016
58
0.030
Why?
Health Education
1
1999
328
0.030
Why?
Alternative Splicing
1
2017
202
0.030
Why?
Genotype
3
2017
1952
0.030
Why?
Severity of Illness Index
2
2017
2876
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
206
0.030
Why?
Disease Management
1
2019
608
0.030
Why?
DNA Methylation
1
1999
496
0.030
Why?
Homeodomain Proteins
1
1998
490
0.030
Why?
Intensive Care Units, Pediatric
1
2016
208
0.030
Why?
HEK293 Cells
1
2017
655
0.030
Why?
Biomarkers, Tumor
1
2021
1075
0.030
Why?
Aged
9
2019
20705
0.030
Why?
Promoter Regions, Genetic
1
1999
1211
0.030
Why?
Sequence Analysis, RNA
1
2016
425
0.030
Why?
Income
1
2014
178
0.030
Why?
Blood Glucose
1
2023
1949
0.030
Why?
Algorithms
1
2021
1618
0.030
Why?
Demography
1
2014
286
0.030
Why?
Marriage
1
2014
114
0.030
Why?
Behavior
1
2014
103
0.030
Why?
Psychomotor Agitation
1
2014
79
0.030
Why?
Base Sequence
1
2016
2217
0.030
Why?
Case-Control Studies
2
2016
3314
0.030
Why?
Clinical Trials as Topic
1
2017
1012
0.030
Why?
In Situ Hybridization, Fluorescence
1
2013
332
0.030
Why?
Odds Ratio
1
2015
1052
0.030
Why?
Nucleoside Transport Proteins
1
2011
4
0.030
Why?
Aggression
1
2014
201
0.030
Why?
Erythrocytes
1
2017
633
0.030
Why?
Antineoplastic Agents, Alkylating
1
2011
70
0.030
Why?
Regression Analysis
1
2014
1049
0.030
Why?
Escherichia coli
1
2015
791
0.030
Why?
Time Factors
2
2015
6889
0.030
Why?
Mice
2
2019
15621
0.030
Why?
Antineoplastic Agents, Phytogenic
1
2011
191
0.020
Why?
Bacteria
1
2016
764
0.020
Why?
Survival Analysis
1
2013
1356
0.020
Why?
Logistic Models
1
2015
2037
0.020
Why?
Obesity
1
2023
2802
0.020
Why?
Prevalence
1
2016
2444
0.020
Why?
Mice, Inbred C57BL
1
2019
5054
0.020
Why?
Kaplan-Meier Estimate
1
2011
901
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Genetic Complementation Test
1
1988
64
0.020
Why?
Cell Fusion
1
1988
52
0.020
Why?
Emotions
1
2014
530
0.020
Why?
Protein C
1
2008
38
0.020
Why?
Antithrombins
1
2008
57
0.020
Why?
Water Microbiology
2
1999
79
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
93
0.020
Why?
Fibrinogen
1
2008
167
0.020
Why?
Genetic Markers
1
1988
371
0.020
Why?
Biomarkers
1
2017
3652
0.020
Why?
Renin-Angiotensin System
1
2007
84
0.020
Why?
Biopsy, Needle
1
2007
189
0.020
Why?
Transplantation, Homologous
1
2008
450
0.020
Why?
Blood Pressure Determination
1
2007
137
0.020
Why?
Rare Diseases
1
2007
109
0.020
Why?
Nephrectomy
1
2007
158
0.020
Why?
Animals
2
2019
34134
0.020
Why?
RNA, Messenger
1
2011
2746
0.010
Why?
Immunohistochemistry
1
2007
1738
0.010
Why?
Cell Line
1
1988
2815
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Menstruation
1
1979
35
0.010
Why?
Estrone
1
1979
34
0.010
Why?
Prolactin
1
1979
101
0.010
Why?
Bolivia
1
1999
59
0.010
Why?
Luteinizing Hormone
1
1979
181
0.010
Why?
Follicle Stimulating Hormone
1
1979
220
0.010
Why?
Restaurants
1
1998
15
0.010
Why?
Food Handling
1
1998
51
0.010
Why?
Swimming
1
1998
48
0.010
Why?
Progesterone
1
1979
248
0.010
Why?
Water Supply
1
1998
75
0.010
Why?
Disease Transmission, Infectious
1
1998
59
0.010
Why?
Meat
1
1998
92
0.010
Why?
Halothane
1
1996
6
0.010
Why?
Estradiol
1
1979
485
0.010
Why?
Feces
1
1998
400
0.010
Why?
Analysis of Variance
1
1999
1383
0.010
Why?
Population Surveillance
1
1999
439
0.010
Why?
Ovarian Neoplasms
1
1978
415
0.010
Why?
Pedigree
3
1978
502
0.010
Why?
Kidney
1
1996
1247
0.010
Why?
Aged, 80 and over
1
1999
6974
0.000
Why?
Nebraska
2
1976
7
0.000
Why?
New York
2
1976
121
0.000
Why?
Genes
1
1978
237
0.000
Why?
Genetic Linkage
1
1978
331
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
63
0.000
Why?
Pheochromocytoma
1
1976
52
0.000
Why?
Klinefelter Syndrome
1
1976
51
0.000
Why?
Syndrome
1
1976
365
0.000
Why?
Pregnancy
2
1978
5663
0.000
Why?
Statistics as Topic
1
1976
328
0.000
Why?
HLA Antigens
1
1976
233
0.000
Why?
Sarcoma
1
1976
134
0.000
Why?
Abnormalities, Multiple
1
1976
179
0.000
Why?
Skin Diseases
1
1976
165
0.000
Why?
Thyroid Neoplasms
1
1976
269
0.000
Why?
Sex Factors
1
1978
1898
0.000
Why?
Neoplasms
2
1976
2241
0.000
Why?
Melanoma
1
1976
705
0.000
Why?
Registries
1
1976
1956
0.000
Why?
Phenotype
1
1976
3078
0.000
Why?
Brain Neoplasms
1
1976
1031
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)